Elevation in CEA level is a well‐known prognostic serologic marker for colorectal cancer (CRC) and is associated with adenocarcinoma of the pancreas, lungs, prostate, ovaries and breast. The gene discussed is CEACAM5; the disease is colorectal carcinoma.